Please select the eligibility criteria that correspond to the clinical trial below.
Title: Telecare in Adults With Type 1 Diabetes Mellitus Treated by Insulin Pump - A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether Telecare can be used for efficient management of adults with Type 1 Diabetes Mellitus using insulin pump, in lieu of frequent clinic visits.


Options:
A: Inclusion Criteria:

* Both genders
* age 50-70 years
* Type two diabetes with at least two-year history of disease and without insulin treatment in the first two years after diagnosis
* Negative medical history for documented previous cardiovascular events or macrovascular complications
* Written consent to participate
* Presence of at least 2 of the following risk factors:

  * LDL cholesterol \> 130 mg/dL (regardless of treatment)
  * Triglycerides \> 200 mg/dL
  * HDL cholesterol \< 35 (males) or 45 (females) mg/dL
  * Blood pressure \> 140/90 mmHg
  * Cigarette smoking

Exclusion Criteria:

* Age below 50 or above 70 years
* Type 1 diabetes, diagnosis before 40 years of age, known presence of auto-antibodies or insulin requirement in the first 2 years of disease.
* Chronic kidney failure (plasma creatinine \> 2 mg/dL)
* Significant liver damage (AST and/or ALT \> 2 times the upper limits of normality)
* History of previous cardiovascular events
* Active neoplasms or any concomitant disease limiting life expectancy
B: Inclusion Criteria:

* Type 2 diabetes mellitus, diagnosis for \> 6 months.
* Age 18-65, participants of either gender- males or females.
* HbA1c between 7.5% and 12.5% within last 6 months (inclusive).
* On stable diabetes therapy for \>3 months prior to enrollment.
* Own an Android Smartphone.
* Participant willing to sign and date written Informed Consent Form to participate in the study.
* Willing to comply with the study schedule and procedures including randomization.

Exclusion Criteria:

* Previously used Gather Health
* Currently using an insulin pump or continuous glucose monitor.
* Pregnant or planning to become pregnant in the next 12 months.
* Severe hearing or visual impairment.
* Active substance, alcohol, or drug abuser (sober \<1 year).
* Any psychiatric illness including psychosis or schizophrenia that will impair the patient's ability to complete the study or follow study protocol.
* Recent major surgery or planning to have major surgery
* Significant renal, hepatic, or other disease that may impair patient's ability to complete the study or follow study protocol
* Using glucocorticoids
* Patients who have received or are planning to receive an organ transplant
C: Inclusion Criteria:

* Patients with T1D lasted \>1 year, age 22 and up, using insulin pump
* Patients possessing a mobile phone and internet access

Exclusion Criteria:

* Patients with Severe target organ damage
* Patients with Mental retardation
* Patients with Eating disorders
* Pregnant patients or patients planning pregnancy
D: Inclusion Criteria:

1. Clinical Diagnosis of Type 2 diabetes mellitus
2. Glycosylated Hemoglobin (HbA1c) \> 7.0 = Uncontrolled
3. Positive score on diabetes related distress 2 question screener and/or
4. Positive score on Patient Health Questionnaire (PHQ-2) 2 question screener

Exclusion Criteria: a diagnosis \[from billing records using International Classification of Disease, 9th Edition (ICD-9) codes\] of:

1. advanced disease (e.g., end stage renal disease, advanced heart failure, blindness, metastatic cancer and including those who are in active treatment for cancer), or
2. alcoholism or
3. cognitive impairment, or
4. major psychiatric disease or
5. any type of physical or mental impairment that would preclude active participation

Answer: C